- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03182036
Portable Oxygen Concentrator Signal Capture Study
April 14, 2021 updated by: ResMed
The main purpose of this study is to learn how patients breathe on portable oxygen concentrators (POCs), and to get feedback from patients using POCs.
Study Overview
Detailed Description
This study aims to examine patient oxygenation levels and markers of exertion (e.g.
breath rate, heart rate and breath pattern) while using a portable oxygen concentrator, with the aim to understand exercise desaturation in hypoxemic subjects.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
Kogarah, New South Wales, Australia, 2217
- St George Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient is willing to give written informed consent
- Patient can read and comprehend English
- Patient is ≥ 18 years of age
- Patient has moderate to severe hypoxaemia (SpO2 ≤ 92%) at rest
- Patient reports shortness of breath on exertion
Exclusion Criteria:
- Patient has musculoskeletal impairment, or other impairment that may be the limiting factor in 6MWT
- Patient has a history of a psychological illness or condition such as to interfere with the patient's ability to understand the requirements of the study
- Patient has acute coronary syndrome, acute myo- or pericarditis, acute lung embolism, pulmonary infarction, acute uncontrolled heart insufficiency
- Patient shows signs of acute exacerbation of underlying lung condition
- Patient is deemed to be unsuitable for inclusion in the opinion of the researcher, including for the following reasons:
- they do not comprehend English
- they are unable to provide written informed consent
- they are physically unable to comply with the protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
Portable pulsed oxygen
|
Hypoxemic patients will use portable pulsed oxygen at rest, and while performing a six-minute walk test.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxygenation
Time Frame: 20 minutes
|
SpO2 during rest and exercise using portable pulsed oxygen therapy
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: 20 minutes
|
Heart rate during rest and exercise using portable pulsed oxygen therapy
|
20 minutes
|
Nasal cannula pressure
Time Frame: 20 minutes
|
Nasal cannula pressure during rest and exercise using portable pulsed oxygen therapy
|
20 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Paul A Dickens, PhD, ResMed
- Study Director: Peter Wlodarczyk, BEng, ResMed
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 26, 2017
Primary Completion (Actual)
August 3, 2017
Study Completion (Actual)
August 3, 2017
Study Registration Dates
First Submitted
May 16, 2017
First Submitted That Met QC Criteria
June 7, 2017
First Posted (Actual)
June 9, 2017
Study Record Updates
Last Update Posted (Actual)
April 19, 2021
Last Update Submitted That Met QC Criteria
April 14, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AR110517
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxia
-
Western University, CanadaUnknownBrain Hypoxia IschemiaCanada
-
Yale UniversityTianjin Chest HospitalCompletedBrain Ischemia Hypoxia | Muscle; Ischemic | Muscle HypoxiaChina
-
Fliegerärztliches InstitutCompleted
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
Owlet Baby Care, Inc.Completed
-
Robert L. OwensCompletedIntermittent HypoxiaUnited States
-
University of Texas at AustinCompleted
-
Harbin Medical UniversityUnknown
-
University Hospital TuebingenUnknown
-
Montreal Heart InstituteUniversité de MontréalCompleted
Clinical Trials on Portable pulsed oxygen
-
Hospital Son EspasesCompletedHypoxia, AltitudeSpain
-
Association Nationale pour les Traitements A Domicile...CompletedChronic Obstructive Pulmonary DiseaseFrance
-
Duke UniversityOdessey II SolutionsWithdrawnOxygen Delivery Systems at Altitude
-
Royal Brompton & Harefield NHS Foundation TrustLiverpool University Hospitals NHS Foundation Trust; National Institute for...CompletedLung; Disease, Fibroid (Chronic)United Kingdom
-
Hvidovre University HospitalDanish Lung AssociationCompleted
-
Inogen Inc.CompletedNocturnal HypoxemiaUnited States
-
Inogen Inc.CompletedHeart FailureCanada
-
Ottawa Hospital Research InstituteInstitute for Rehabilitation Research and Development, The Ottawa Hospital...CompletedPulmonary Fibrosis | Chronic Obstructive Lung DiseaseCanada